Статья
Артериальная гипертензия у беременных: дискуссионные вопросы национальных и международных рекомендаций
Гипертонические расстройства беременности, включающие в себя уже существующую и гестационную гипертензию, преэклампсию и эклампсию, осложняют до 10% беременностей и представляют собой значительную причину материнской и перинатальной заболеваемости и смертности. Несмотря на некоторые различия в руководящих принципах, существует консенсус в отношении того, что необходимо контролировать тяжелую артериальную гипертензию (АГ) и нетяжелую АГ с признаками органной дисфункции. Тем не менее, достижение целевых значений ниже 160/110 мм рт.ст. остаются дис-кутабельными. В обзоре представлены современные позиции, отражающие определение, классификацию, цели терапии и принципы лечения, используемые при гипертензивных расстройствах во время беременности и в послеродовый период, в сравнительном аспекте национальных и международных рекомендаций.
1. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22. doi:10.1016/S0002-9378(00)40820-3.
2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins— Obstetrics. ACOG practice bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26-e50. doi:10.1097/AOG.0000000000003020.
3. ACOG practice bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:e1-e25. doi:10.1097/AOG.0000000000003018.
4. Butalia S, Audibert F, Cote AM, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34(5):526-31. doi:10.1016/j.cjca.2018.02.021.
5. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-241. doi:10.1093/eurheartj/ehy340.
6. Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36:416-41. doi:10.1016/s1701-2163(15)30588-0.
7. Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104. doi:10.1016/j.preghy.2014.02.001.
8. Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310. doi:10.1016/j.preghy.2018.05.004.
9. Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55:e1-29. doi:10.1111/ajo.12399.
10. Webster K, Fishburn S, Maresh M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366:l5119. doi:10.1136/bmj.l5119.
11. Диагностика и лечение сердечно-сосудистых заболеваний при беременности: Национальные рекомендации. Российский кардиологический журнал. 2018;(3):91-134. doi:10.15829/1560-4071-2018-3-91-134.
12. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол). М. 2016. с.72.
13. Кобалава Ж. Д., Конради А. О., Недогода С. В. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786.
14. Bernstein PS, Martin JN, Barton JR, et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 2017;46:776-87. doi:10.1016/j.jogn.2017.05.003.
15. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118:214-27. doi:10.1378/chest.118.1.214.
16. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138:e426-e483. doi:10.1161/CIR.0000000000000597.
17. Leffert LR, Clancy CR, Bateman BT, et al. Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet Gynecol. 2015;125(1):124-31. doi:10.1097/AOG.0000000000000590.
18. Magee LA, von Dadelszen P, Singer J, et al. The CHIPS randomized controlled trial (control of hypertension in pregnancy study): is severe hypertension just an elevated blood pressure. Hypertension. 2016;68(5):1153-9. doi:10.1161/HYPERTENSIONAHA.116.07862.
19. Чулков В. С., Вереина Н. К., Синицын С. П. и др. Оценка взаимосвязи достижения целевого артериального давления с осложнениями и исходами беременности при артериальной гипертензии. Кардиоваскулярная терапия и профилактика. 2014;13(6):23-7. doi:10.15829/1728-8800-2014-6-23-27.
20. Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252. doi:10.1002/14651858.CD002252.pub4.
21. Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407-17. doi:10.1056/NEJMoa1404595.
22. Pels A, Mol BWJ, Singer J, et al. Influence of gestational age at initiation of antihypertensive therapy: secondary analysis of CHIPS trial data (control of hypertension in pregnancy study). Hypertension. 2018;71(6):1170-7. doi:10.1161/HYPERTENSIONAHA.117.10689.
23. Chronic Hypertension and Pregnancy (CHAP) Project (CHAP). Ongoing clinical trial. https://clinicaltrials.gov/ct2/show/NCT02299414.
24. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;7:CD001449. doi:10.1002/14651858.CD001449.pub3.
25. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955-60. doi:10.1136/bmj.327.7421.955.
26. Shekhar S, Gupta N, Kirubakaran R, et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016;123(1):40-7. doi:10.1111/1471-0528.13463.
27. Manzur-Verastegui S, Mandeville PB, Gordillo-Moscoso A, et al. Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial. Clin Exp Pharmacol Physiol. 2008;35(5-6):580-5. doi:10.1111/j.1440-1681.2007.04838.x.
28. Williams B, Mancia G, Spiering W, et al. 2018 practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2018;36:2284-309. doi:10.1097/HJH.0000000000001961.
29. Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anaesthesia. 2012;67(6):646-59. doi:10.1111/j.1365-2044.2012.07055.x.
30. Altman D, Carroli G, Duley L, et al. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877-90. doi:10.1016/s0140-6736(02)08778-0.31.
31. Belfort MA, Anthony J, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003;348:304-11. doi:10.1056/ NEJMoa021180.
32. Hoeltzenbein M, Beck E, Fietz AK, et al. Pregnancy outcome after first trimester use of methyldopa: a prospective cohort study. Hypertension. 2017;70(1):201-8. doi:10.1161/HYPERTENSIONAHA.117.09110.
33. Чулков В. С., Синицын С. П., Вереина Н. К. и др. Особенности структуры, анамнеза и исходы беременности при артериальной гипертензии. Экология человека. 2009;10:49-54.
34. Cockburn J, Moar VA, Ounsted M, et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet. 1982;1(8273):647-9. doi:10.1016/S0140-6736(82)92202-4.
35. Magee LA, von Dadelszen P, Singer J, et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the control of hypertension in pregnancy study (CHIPS) trial. BJOG. 2016;123(7):1143-51. doi:10.1111/1471-0528.13569.
36. Xie RH, Guo Y, Krewski D, et al. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;175:124-8. doi:10.1016/j.ejogrb.2014.01.019.
37. Stott D, Bolten M, Salman M, et al. A prediction model for the response to oral labetalol for the treatment of antenatal hypertension. J Hum Hypertens. 2017;31(2):126-31. doi:10.1038/jhh.2016.50.
38. Plouin PF, Breart G, Maillard F, et al. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol. 1988;95(9):868-76. doi:10.1111/j.1471-0528.1988.tb06571.x.
39. Sibai BM, Mabie WC, Shamsa F, et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162:960-6; discussion 966-7. doi:10.1016/0002-9378(90)91297-p.
40. Molvi SN, Mir S, Rana VS, et al. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Arch Gynecol Obstet. 2012;285(6):1553-62. doi:10.1007/s00404-011-2205-2.
41. Shawkat E, Mistry H, Chmiel C, et al. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy. Pregnancy Hypertens. 2018;11:92-8. doi:10.1016/j.preghy.2017.12.007.
42. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301:587-9. doi:10.1136/bmj.301.6752.587.
43. Xie RH, Guo Y, Krewski D, et al. в-blockers increase the risk of being born small for gestational age or of being institutionalized during infancy. BJOG. 2014;121(9):1090-6. doi:10.1111/1471-0528.12678.
44. Bateman BT, Heide-Jorgensen U, Einarsdottir K, et al. в-blocker use in pregnancy and the risk for congenital malformations: an international cohort study. Ann Intern Med. 2018;169(10):665-73. doi:10.7326/M18-0338.
45. Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy beta blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics. 2016;138(3):e20160731. doi:10.1542/peds.2016-0731.
46. Magee LA, Schick B, Donnenfeld AE, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol. 1996;174(3):823-8. doi:10.1016/s0002-9378(96)70307-1.
47. Webster LM, Myers JE, Nelson-Piercy C, et al. Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial. Hypertension. 2017;70(5):915-22. doi:10.1161/HYPERTENSIONAHA.117.09972.
48. Ahn HK, Nava-Ocampo AA, Han JY, et al. Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding. Hypertens Pregnancy. 2007;26(2):179-87. doi:10.1080/10641950701204554.
49. Vigil-De Gracia P, Dominguez L, Solis A. Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial. J Matern Fetal Neonatal Med. 2014;27:1291-4. doi:10.3109/14767058.2013.852180.
50. Bramham K, Nelson-Piercy C, Brown MJ, et al. Postpartum management of hypertension. BMJ. 2013;346:f894. doi:10.1136/bmj.f894.
51. Matthys LA, Coppage KH, Lambers DS, et al. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190(5):1464-6. doi:10.1016/j.ajog.2004.02.037.
52. Yancey LM, Withers E, Bakes K, et al. Postpartum preeclampsia: emergency department presentation and management. J Emerg Med. 2011;40(4):380-4. doi:10.1016/j.jemermed.2008.02.056.
53. Ghuman N, Rheiner J, Tendler BE, et al. Hypertension in the postpartum woman: clinical update for the hypertension specialist. J Clin Hypertens. 2009;11(12):726-33. doi:10.1111/j.1751-7176.2009.00186.x.
54. World Health Organization. WHO Recommendations for Prevention and Treatment of Preeclampsia and Eclampsia. Geneva. 2011. p. 38. ISBN: 978 92 4 154833 5.
55. Amro FH, Moussa HN, Ashimi OA, et al. Treatment options for hypertension in pregnancy and puerperium. Expert Opin Drug Saf. 2016;15(12):1635-42. doi:10.1080/14740338.2016.1237500.
56. Moroz LA, Simpson LL, Rochelson B. Management of severe hypertension in pregnancy. Semin Perinatol. 2016;40(2):112-8. doi:10.1053/j.semperi.2015.11.017.
57. Малахов В. В., Федоров А. А., Гуляев В. Ю. и др. Применение электростимулятора чрескожного “АВР-051” для коррекции артериального давления в клинической практике: методические рекомендации. Екатеринбург: УГМУ. 2018. с.27. ISBN 978-5-907080-13-3.
58. Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX-XIV. doi:10.1081/PRG-100104165.